Quarterly Results June 30, 2026

12th August, 2026 The General Manager-Listing Corporate Relationship Department BSE Limited, Ground Floor, P.J. Towers, Dalal Street, Mumbai. Scrip Code: 531960 Sub: Outcome of Meeting of Board of Directors Held on Wednesday, August 12, 2026 Ref: Disclosure under Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015. Dear Sir/Madam, With reference to above subject and in compliance with Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e. Wednesday, August 12, 2026 has considered and approved the following: - 1. Un-Audited Financial Results (UFR) for the quarter ended June 30, 2026, along with the and Exchange Board of India (Listing Obligations and Disclosure Requirements) SRteagtuultaotriyo nAsu, 2d0it1o5rs. ’ Limited Review Report pursuant to Regulation 33 of the Securities 2. Reviewed the other business of the company. You are requested to kindly take the same on record. The Board Meeting commenced at 4.00 P.M. and concluded at 4.50 P.M. Thanking you, Yours faithfully For, June Industries Limited (Formerly known as Kashyap Tele-Medicines Limited) KALPESH BIPIN SHETH Managing Director (DIN: 00405151) Encl. as above June Industries Limited (Formerly known as Kashyap Tele-Medicines Limited ) CIN: L46497MH1995PLC085738 Regd. Off.: Unit No.22 & 23, Hasti Industrial Premises Co-Op Soc Ltd, Plot No R-798, Mahape, MIDC,Navi Mumbai, Ghansoli, Thane, Rabale, Maharashtra, India, 400701 Phone: +91-8976792931, Email: investors@june4gmp.com Website: www.kashyaptele-medicines.com STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER 30TH JUNE 2026 (As Per Regulation 33 OF SEBI (LODR) Regulations, 2015 & Schedule III Companies Act, 2013 read with IND-AS ) Amount (Rs.) in Lakhs Quarter Ended Year Ended Particulars 30-06-2026 31-03-2026 30-06-2025 31-03-2026 (Unaudited) (Refer Note 4) (Refer Note 4) (Audited) Income Revenue from operations 2 0.00 1 9.70 0.00 19.70 Other income 0 .16 1 .63 0.00 1.88 Total income 20.16 21.33 0.00 21.58 Expenses Employee benefits expense 0 .75 0 .60 0.11 1.91 Finance Charges 0 .18 - - - Other expenses 4 .78 4 8.71 2.87 65.73 Total expenses 5.70 49.31 2.98 67.64 Profit/(loss) before exceptional and extraordinary items and tax 14.46 (27.98) (2.98) (46.06) Exceptional items 0.00 0.00 0.00 0.00 Profit before Extraordinary items and tax 14.46 ( 27.98) (2.98) (46.06) Extraordinary items 0.00 0.00 0.00 0.00 Profit/(loss) before taxes 14.46 ( 27.98) (2.98) (46.06) Tax expense: Current tax 0.00 0.00 0.00 0.00 Tax relating to previous year 0.00 0.00 0.00 0.00 Income tax expense 0.00 0.00 0.00 0.00 Profit / (Loss) for the period from Continuing Operations 14.46 ( 27.98) (2.98) (46.06) Profit/(loss) from Discontinuing Operations 0.00 0.00 0.00 0.00 Tax Expense of Discontinuing Operations 0.00 0.00 0.00 0.00 Profit/(loss) from Discontinuing operations (after tax) 0.00 0.00 0.00 0.00 Profit / (Loss) for the period 14.46 ( 27.98) (2.98) (46.06) Share of profit / (loss) of Associates Minority interest 0.00 0.00 0.00 0.00 Profit / (Loss) after taxes, minority interest and share of profit / (loss) of associates 14.46 ( 27.98) (2.98) (46.06) Other Comprehensive Income A. Items that will be/will not be reclassified to profit and loss 0.00 0.00 0.00 0.00 B. Income tax relating to items that will be / will not be reclassified to profit and loss 0.00 0.00 0.00 0.00 Total comprehensive income for the period 14.46 ( 27.98) (2.98) (46.06) Paid-up Equity Share Capital (Face Value of Rs. 1/- each) 4 77.22 4 77.22 4 77.22 477.22 Other Equity excluding revaluation reserves (444.88) (459.34) ( 459.34) Earnings per equity share Basic and Diluted 0.030 (0.059) (0.006) (0.097) The accompanying notes form an integral part of these financials statements. Place : Mumbai For and on behalf of the Board of Directors of Date : 12/08/2026 June Industries Limited (Formerly known as Kashyap Tele-Medicines Limited ) (Mr.Kalpesh Sheth) Managing Director (DIN: 00405151) Notes to Unaudited Financial Results for the quarter ended 30th June, 2026: 1 TheaboveUnauditedFinancialResults oftheCompanyforthequarterended30thJune,2026havebeen reviewed & recommended by the Audit Committee and approved by the Board of Directors in the Meeting held on 12th August, 2026. The same have been subjected to Limited Review by the Statutory Auditors of the company. The above financial results have been prepared in accordance with the Companies (Indian Accounting 2 Standards) Rules, 2015 (Ind AS) prescribed under section 133 of the Companies Act, 2013 and other recognised accouting practices & policies to the extent applicable. The Company is engaged in single segment i.e. 'Trading of pharmaceuticals hygiene and cleanroom 3 products', therefore has only one reportable segment in accordance with Ind AS 108 'operating segments'. The Financial Result for the quarter ended 31st March, 2026 are the balancing figures between audited figures in respect of the full financial year ended on 31st March, 2026 and the published year-to-date figures upto the Third quarter ended 31st December, 2025. The Company’s name was changed from Kashyap Tele-Medicines Limited to June Industries Limited, effective 30th December, 2025. A Copy of the aforesaid financial results is also available on the website of BSE Limited (www.bseindia.com) and on the website of the Company (www.kashyaptele-medicines.com). 7 Figures pertaining to previous year/periods have been re-grouped and re-arranged wherever necessary. For and on behalf of Board of Directors of For June Industries Limited Date : 12/08/2026 Place : Mumbai KALPESH BIPIN SHETH Managing Director DIN: 00405151